首页> 美国卫生研究院文献>Aging (Albany NY) >The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma
【2h】

The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma

机译:MicroRNA miR-29c-5p通过靶向TMEM98在头部和颈部癌中抑制细胞增殖和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Head and neck squamous cell carcinoma (HNSCC), which occurs frequently worldwide, is characterized by high risk of metastasis. MicroRNAs (miRNAs) play crucial roles in tumorigenesis and cancer development. In this study, miR-29c-5p was identified using three high throughput microarrays. We measure miR-29c-5p expression in HNSCC tissues and cell lines. To determine the function of miR-29c-5p in HNSCC, we evaluated its effects in vitro on cell proliferation, the cell cycle, apoptosis, and cell migration. We employed a mouse tumor xenograft model to determine the effects of miR-29c-5p on tumors generated by HNSCC cell lines. The miR-29c-5p expression was lower in HNSCC tissues than in normal tissues. Upregulated miR-29c-5p expression in HNSCC cells inhibited migration and arrested cells in the G2/M phase of the cell cycle. Further, upregulated miR-29c-5p expression inhibited the proliferation of HNSCC cells in vivo and in vitro. In addition, transmembrane protein 98 (TMEM98) was identified as a direct target of miR-29c-5p by using a luciferase reporter assay. These findings provide new insights that link the regulation of miR-29c-5p expression to the malignant phenotype of HNSCC and suggest that employing miR-29c-5p may serve as a therapeutic strategy for managing patients with HNSCC.
机译:在全球经常发生的头部和颈部鳞状细胞癌(HNSCC)的特征在于转移的高风险。 MicroRNA(miRNA)在肿瘤内酯和癌症发育中起着至关重要的作用。在该研究中,使用三种高通量微阵列鉴定miR-29c-5p。我们测量HTSCC组织和细胞系中的miR-29c-5p表达。为了确定HNSCC中miR-29c-5p的功能,我们在体外评估了细胞增殖,细胞周期,细胞凋亡和细胞迁移的影响。我们使用小鼠肿瘤异种移植模型,以确定miR-29c-5p对HNSCC细胞系产生的肿瘤的影响。 HNSCC组织中的miR-29c-5p表达低于正常组织。 HNSCC细胞中的上调MIR-29C-5P表达抑制细胞周期的G2 / M阶段的迁移和阻滞细胞。此外,上调的MiR-29C-5P表达抑制体内和体外HNSCC细胞的增殖。此外,通过使用荧光素酶报告器测定,将跨膜蛋白98(TMEM98)鉴定为miR-29c-5p的直接靶标。这些发现提供了新的见解,将MiR-29C-5P表达的调节联系起来对HNSCC的恶性表型,并建议使用MIR-29C-5P可以作为管理HNSCC患者的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号